Biosergen AS Financial Flexibility Index
Biosergen AS financial flexibility index. Biosergen AS (BIOSGN) has a Financial Flexibility Index of -0.59x as of December 2025. Free cash flow of Skr-7.75 Million (operating CF Skr-7.75 Million minus capex Skr0.00) represents -1% of total liabilities (Skr13.04 Million). See Biosergen AS (BIOSGN) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Biosergen AS (2019–2025)
Financial flexibility index of Biosergen AS from 2019 to 2025. Historical Financial Flexibility Index trend for Biosergen AS across 7 annual periods. Explore cash flow to debt ratio of Biosergen AS to assess how comfortably operating cash covers total debt obligations.
Biosergen AS Financial Flexibility Index by Year (2019–2025)
Biosergen AS financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for Biosergen AS. For the full cash flow conversion analysis, see how efficiently does Biosergen AS generate cash.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.73x | Skr-35.53 Million | Skr-35.53 Million | Skr13.04 Million | ▲ +39.2% |
| 2024 | -4.48x | Skr-16.63 Million | Skr-16.63 Million | Skr3.71 Million | ▲ +30.1% |
| 2023 | -6.41x | Skr-32.60 Million | Skr-32.60 Million | Skr5.08 Million | ▼ -139.5% |
| 2022 | -2.68x | Skr-29.44 Million | Skr-29.44 Million | Skr11.00 Million | ▲ +34.4% |
| 2021 | -4.08x | Skr-37.75 Million | Skr-37.75 Million | Skr9.25 Million | ▼ -1299.1% |
| 2020 | -0.29x | Skr-4.58 Million | Skr-4.58 Million | Skr15.72 Million | ▼ -43.2% |
| 2019 | -0.20x | Skr-2.31 Million | Skr-2.31 Million | Skr11.37 Million | — |